Clinical significance of pAkt and pErk1/2 expression in early-stage breast cancer patients treated with anthracycline-based adjuvant chemotherapy

The expression of phosphorylated Akt (pAkt) and phosphorylated extracellular-regulated kinase 1/2 (pErk1/2) proteins may result in breast cancer progression and drug resistance in vitro, however, compelling evidence regarding the clinical significance of pAkt and pErk1/2 in early-stage breast cancer...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncol Lett
Autori principali: LIU, WENJUAN, ZHANG, LINGYUN, SHI, JING, LIU, YUNPENG, ZHOU, LIZHONG, HOU, KEZUO, QU, XIUJUAN, TENG, YUEE
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2015
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4356398/
https://ncbi.nlm.nih.gov/pubmed/25789027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2015.2965
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi